|
?:authorAffiliation
|
-
[\'National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, Via Portuense, 292-00149, Rome, Italy.\', \'Institutes for Translational Medicine, Soochow University Medical College, Suzhou, China.\', \'Institute of Health Sciences, Chinese Academy of Sciences, Shanghai, China.\', \'Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, 100039, Beijing, China.\', \'Department of Molecular Medicine, University of Rome \'Sapienza\', Rome, Italy.\', \'Department of Biology, University of Rome \'Tor Vergata\', Rome, Italy.\', \'Immunotherapy Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal.\', \'I Med Clinic, University of Mainz, Mainz, Germany.\', \'Division of Infection and Immunity, University College London, London, UK.\', \'National Institute or Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.\', \'National Institute for Infectious Diseases, Lazzaro Spallanzani-IRCCS, Via Portuense, 292-00149, Rome, Italy. giuseppe.ippolito@inmi.it.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}